NeuroPace, Inc. Reaffirmed earnings guidance for the year 2024. For the period, the company expects total revenue to range between $73 million and $77 million, representing growth of 12% to 18% over 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.53 USD | -0.92% | -5.64% | -26.96% |
05-13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
05-08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.96% | 217M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.70% | 65.19B | |
+15.38% | 53.02B | |
+3.64% | 50.28B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- NPCE Stock
- News NeuroPace, Inc.
- NeuroPace, Inc. Reaffirms Earnings Guidance for the Year 2024